Conditions: Pancreatic Cancer; Pancreatic Disease; Microbial Colonization
Intervention: Other: No any intervention
Sponsor: Ruijin Hospital
Recruiting
Feeds
3807 items (3807 unread) in 74 feeds
Acinar Cell Carcinoma
(40 unread)
Acinic Cell Carcinoma
(50 unread)
Adenoid Cystic Carcinoma
(96 unread)
Adrenal Gland Cancer
(350 unread)
Ampulla Of Vater
(53 unread)
Anal Cancer
(367 unread)
Angiosarcoma
(88 unread)
Appendix Cancer
(50 unread)
Bile Duct Cancer
(400 unread)
Brain and CNS
(353 unread)
Carcinoid
(144 unread)
Endocrine/Neuroendocrine
(453 unread)
Gall Bladder Cancer
(301 unread)
Hemangioendothelioma
(90 unread)
Hepatoblastoma
(50 unread)
Pancreas
(28 unread)
Phyllodes
(17 unread)
PMP and Mucinous Tumors
(22 unread)
Rhabdomyosarcoma
(212 unread)
Sarcoma
(643 unread)
Trial - Neuroendocrine Cancers (13 unread)
-
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases
Posted: January 14th, 2022, 3:00pm GMT
-
A Clinical Trial of TAA06 Injection in Advanced Solid Tumors
Posted: January 13th, 2022, 3:00pm GMT
Condition: Malignant Melanoma, Lung Cancer, or Colorectal Cancer
Intervention: Biological: TAA06 injection
Sponsors: PersonGen BioTherapeutics (Suzhou) Co., Ltd.; Department of Immunology, The Fourth Hospital of Hebei Medical University
Recruiting -
Lutathera and ASTX727 in Neuroendocrine Tumours
Posted: January 5th, 2022, 3:00pm GMT
Condition: Neuroendocrine Tumors
Intervention: Drug: ASTX727
Sponsors: Imperial College London; Advanced Accelerator Applications, a Novartis company
Not yet recruiting -
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
Posted: January 4th, 2022, 3:00pm GMT
Conditions: Neoplasms; Neoplasm Metastasis; Metastatic Gastrointestinal Carcinoid Tumor
Intervention: Drug: EMB-01
Sponsors: Shanghai EpimAb Biotherapeutics Co., Ltd.; Covance
Recruiting -
Lifileucel and Pembrolizumab for the Treatment of Locally Advanced Stage IIIB-D Melanoma
Posted: January 4th, 2022, 3:00pm GMT
Conditions: Locally Advanced Melanoma; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8
Interventions: Drug: Cyclophosphamide; Drug: Fludarabine; Biological: Lifileucel; Biological: Pembrolizumab; Procedure: Therapeutic Conventional Surgery
Sponsors: Richard Wu; Iovance Biotherapeutics, Inc.
Not yet recruiting -
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
Posted: December 27th, 2021, 3:00pm GMT
Condition: Metastatic Uveal Melanoma
Interventions: Drug: Binimetinib; Drug: Belinostat
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Pfizer; Acrotech Biopharma
Recruiting -
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Posted: December 24th, 2021, 3:00pm GMT
Conditions: Solid Tumor; Breast Tumor; Colon Tumor, Malignant; Lung Tumor; Urologic Cancer; Pancreatic Cancer; Melanoma; Metastatic Cancer; Locally Advanced Solid Tumor; Esophageal Cancer; Endometrial Cancer; Head and Neck Cancer
Intervention: Drug: Niraparib
Sponsor: Tempus Labs
Not yet recruiting -
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
Posted: December 23rd, 2021, 3:00pm GMT
Conditions: Neuroendocrine Tumors; Carcinoma;Endocrine
Intervention: Other: Histologically confirmed neuroendocrine tumor
Sponsor: Latin American Cooperative Oncology Group
Recruiting -
Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC
Posted: December 21st, 2021, 3:00pm GMT
Condition: Neuroendocrine Neoplasm
Interventions: Drug: Sintilimab; Drug: IBI310; Drug: Surufatinib
Sponsor: Peking University
Recruiting -
Cancer and Blood Pressure Management, CARISMA Study
Posted: July 10th, 2020, 2:00pm GMT
Conditions: Cardiovascular Disorder; Chronic Kidney Disease; Metastatic Renal Cell Carcinoma; Metastatic Thyroid Gland Medullary Carcinoma; Stage IV Renal Cell Cancer AJCC v8; Stage IV Thyroid Gland Medullary Carcinoma AJCC v8; Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8; Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8; Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
Interventions: Other: Best Practice; Other: Blood Pressure Measurement; Other: Clinical Management; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI)
Recruiting -
Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma
Posted: June 30th, 2020, 2:00pm GMT
Condition: Large-Cell Neuroendocrine Carcinoma
Interventions: Other: Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma; Other: Treatment for Small Cell Lung Cancer
Sponsor: Aman Chauhan
Recruiting -
Microbial Diversity of Pancreatic Diseases
Posted: January 18th, 2019, 3:00pm GMT
Conditions: Pancreatic Cancer; Pancreatic Disease
Intervention:
Sponsor: Ruijin Hospital
Recruiting -
Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
Posted: November 3rd, 2015, 3:00pm GMT
Conditions: Gastric Neuroendocrine Carcinoma; Intestinal Neuroendocrine Carcinoma; Pancreatic Neuroendocrine Carcinoma
Interventions: Drug: Capecitabine; Drug: Carboplatin; Drug: Cisplatin; Drug: Etoposide; Other: Laboratory Biomarker Analysis; Drug: Temozolomide
Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI)
Recruiting